149 related articles for article (PubMed ID: 37576325)
1. Widefield choroidal vasculature associated with future condition of subretinal fluid in central serous chorioretinopathy.
Kogo T; Muraoka Y; Ishikura M; Nishigori N; Ueda-Arakawa N; Miyata M; Tamura H; Hata M; Takahashi A; Miyake M; Tsujikawa A
Heliyon; 2023 Aug; 9(8):e18441. PubMed ID: 37576325
[TBL] [Abstract][Full Text] [Related]
2. Widefield Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source OCT.
Ishikura M; Muraoka Y; Nishigori N; Takahashi A; Miyake M; Ueda-Arakawa N; Miyata M; Ooto S; Tsujikawa A
Ophthalmol Retina; 2022 Oct; 6(10):949-956. PubMed ID: 35436598
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional choroidal vascularity index in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography.
Zeng Q; Luo L; Yao Y; Tu S; Yang Z; Zhao M
Front Med (Lausanne); 2022; 9():967369. PubMed ID: 36160148
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of choroidal vasculature in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography.
Zeng Q; Yao Y; Tu S; Zhao M
Sci Rep; 2022 Nov; 12(1):18427. PubMed ID: 36319689
[TBL] [Abstract][Full Text] [Related]
5. Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy.
Borrelli E; Zuccaro B; Zucchiatti I; Parravano M; Querques L; Costanzo E; Sacconi R; Prascina F; Scarinci F; Bandello F; Querques G
J Clin Med; 2019 Aug; 8(9):. PubMed ID: 31443376
[No Abstract] [Full Text] [Related]
6. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
[TBL] [Abstract][Full Text] [Related]
7. Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
Seo EJ; Um T; Yoon YH
Clin Exp Ophthalmol; 2019 May; 47(4):505-512. PubMed ID: 30515936
[TBL] [Abstract][Full Text] [Related]
8. Association of Subretinal Fluid Duration and Baseline Chorioretinal Structure With Optical Coherence Tomography in Central Serous Chorioretinopathy.
Suzuki T; Sasajima H; Otaki C; Ueta Y; Tate H
Transl Vis Sci Technol; 2023 Oct; 12(10):12. PubMed ID: 37831445
[TBL] [Abstract][Full Text] [Related]
9. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
Pang CE; Shah VP; Sarraf D; Freund KB
Am J Ophthalmol; 2014 Aug; 158(2):362-371.e2. PubMed ID: 24794091
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Retinal Layer Thickness and Capillary Vessel Density in the Patients with Spontaneously Resolved Acute Central Serous Chorioretinopathy.
Han KJ; Kim HJ; Woo JM; Min JK
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375674
[TBL] [Abstract][Full Text] [Related]
11. CHANGE OF CHOROIDAL VOLUME IN UNTREATED CENTRAL SEROUS CHORIORETINOPATHY.
Pertl L; Haas A; Hausberger S; Pichler T; Rabensteiner DF; Seidel G; Malle EM; Weger M
Retina; 2017 Sep; 37(9):1792-1796. PubMed ID: 27941529
[TBL] [Abstract][Full Text] [Related]
12. Choroidal Thickness Changes After Photodynamic Therapy and Recurrence of Chronic Central Serous Chorioretinopathy.
Kim YK; Ryoo NK; Woo SJ; Park KH
Am J Ophthalmol; 2015 Jul; 160(1):72-84.e1. PubMed ID: 25887629
[TBL] [Abstract][Full Text] [Related]
13. Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study.
Durmaz Engin C; Kayabasi M; Koksaldi S; Ipek SC; Saatci AO
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103634. PubMed ID: 37244453
[TBL] [Abstract][Full Text] [Related]
14. Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy.
Kwak JH; Hong SW; Ra H; Kim EC; Kang NY; Baek J
Korean J Ophthalmol; 2019 Dec; 33(6):493-499. PubMed ID: 31833245
[TBL] [Abstract][Full Text] [Related]
15. Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy.
Goktas A
Eye (Lond); 2014 Dec; 28(12):1431-6. PubMed ID: 25233823
[TBL] [Abstract][Full Text] [Related]
16. Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy.
Falavarjani KG; Amirsardari A; Habibi A; Eshaghi A; Bakhti S; Aghdam KA
J Ophthalmic Vis Res; 2017; 12(3):281-289. PubMed ID: 28791061
[TBL] [Abstract][Full Text] [Related]
17. Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy.
Faghihi H; Mohammadzadeh V; Nabavi A; Faghihi S; Kadivar S; Ghassemi F
Ophthalmic Surg Lasers Imaging Retina; 2019 Nov; 50(11):726-733. PubMed ID: 31755972
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
[TBL] [Abstract][Full Text] [Related]
19. Analysis of widefield choroidal thickness maps of healthy eyes using swept source optical coherence tomography.
Hirano M; Muraoka Y; Kogo T; Ishikura M; Nishigori N; Ueda-Arakawa N; Miyata M; Hata M; Takahashi A; Miyake M; Tsujikawa A
Sci Rep; 2023 Jul; 13(1):11904. PubMed ID: 37488140
[TBL] [Abstract][Full Text] [Related]
20. Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes.
Son KY; Lim SG; Hwang S; Choi J; Kim SJ; Kang SW
Br J Ophthalmol; 2024 May; ():. PubMed ID: 38789130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
